Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Register-based Study on Ticagrelor 60 mg Persistence and Event Rates in Clinical Practice in the US and Europe.

NCT04568083 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04568083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04568083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Register-based Study on Ticagrelor 60 mg Persistence and Event Rates in Clinical Practice in the US and Europe.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 25, 2020
Completion date
June 28, 2021
Enrollment
7,035 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction (mi)